Yearly Publication Trends - malaria vaccine

Year	Publication Count
2024	164
2023	400
2022	273
2021	267
2020	151
2019	146
2018	86
2017	115
2016	99
2015	84
2014	103

Relevant Publications

Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study.

Issue Release: 2024

Getting closer to an effective multi-stage malaria vaccine.

Issue Release: 2024

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.

Issue Release: 2024

Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review.

Issue Release: 2024

A review on RNA interference studies in Anophelines to reveal candidate genes for malaria transmission blocking vaccine.

Issue Release: 2024

A new landscape for malaria vaccine development.

Issue Release: 2024

How to Accelerate Early Stage of Malaria Vaccine Development by Optimizing Functional Assays.

Issue Release: 2024

From multiplicity of infection to force of infection for sparsely sampled populations at high transmission.

Issue Release: 2024

Identification of immunoreactive antigens by phage display cDNA screen.

Issue Release: 2024

A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.

Issue Release: 2024

Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation.

Issue Release: 2024

Design and Evaluation of Chimeric Circumsporozoite Protein-Based Malaria Vaccines.

Issue Release: 2024

A 3D organoid platform that supports liver-stage infection can be used to identify intrahepatic antimalarial drugs.

Issue Release: 2024

Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.

Issue Release: 2024

Leveraging malaria vaccines and mRNA technology to tackle the global inequity in pharmaceutical research and production towards disease elimination.

Issue Release: 2024

The biology and pathogenesis of vivax malaria.

Issue Release: 2024

Genetic diversity and natural selection of plasmodium vivax Merozoite surface protein 8 in global populations.

Issue Release: 2024

Exploring malaria parasite surface proteins to devise highly immunogenic multi-epitope subunit vaccine for Plasmodium falciparum.

Issue Release: 2024

Targeting Prohibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine development.

Issue Release: 2024

Declining antibody affinity over time after human vaccination with a Plasmodium falciparum merozoite vaccine candidate.

Issue Release: 2024

Why are VDPVs a concern?

What Are the Key Stages in Vaccine Production?

Why is Incidence Rate Important in Vaccine Studies?

How Do Pathogens Evolve and Affect Vaccine Efficacy?

Can Vaccines Prevent All Types of Pneumonia?

How Do Scientists Address Genetic Variability in Vaccine Design?

What is Measles?

How does the VSD work?

How Effective is the HPV Vaccine?

How Do Vaccines Boost the Immune System?

Partnered Content Networks

Relevant Topics